Former Private Equity Partner, OrbiMed Advisors
Chau Quang Khuong is Former Partner in the Private Equity group at OrbiMed Advisors, a global healthcare-dedicated investment firm with approximately $15 billion in assets under management.
During his career, Mr. Khuong has been an active investor in innovative drug development and medical device enterprises across all stages and therapeutic areas including oncology, infectious diseases, and ophthalmology.
He currently serves as a Board director of numerous public and private companies, including Aerpio Therapeutics, Inc., Cerapedics, Greybug, Immatics, Inspire Medical Systems, Nabriva (NASDAQ: NBVR), NextCure, Otonomy, Inc. (NASDAQ: OTIC), Pieris Pharmaceuticals (NASDAQ: PIRS), ReViral Ltd, and Synlogic.
He holds a B.S. in molecular, cellular and developmental biology with concentration in biotechnology and an MPH with concentration in infectious diseases, both from Yale University.